Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Fuji

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|March 23, 2026
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantationShigeo Fuji, Akihiro Ohmoto, Yuho Najima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2017
Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell TransplantationIchiro Kawashima, Yoshihiro Inamoto, Akiko Miyagi Maeshima, et al.
British Journal of Haematology|December 1, 2023
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantationShigeo Fuji, Junichi Sugita, Yuho Najima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2019
Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working GroupAkihito Shinohara, Kumi Oshima, Shigeo Fuji, et al.
Annals of Hematology|January 15, 2022
Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphomaAkio Onishi, Shigeo Fuji, Shigehisa Kitano, et al.
Bone Marrow Transplantation|May 8, 2021
Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donorsSouichi Shiratori, Junichi Sugita, Shigeo Fuji, et al.
Bone Marrow Transplantation|August 7, 2023
Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular TherapyShigeo Fuji, Akitoshi Hakoda, Junya Kanda, et al.
Annals of Hematology|November 10, 2023
Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infectionKatsuto Takenaka, Shigeo Fuji, Toshihiro Matsukawa, et al.
Bone Marrow Transplantation|April 30, 2021
Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantationKaito Harada, Shun-Ichi Kimura, Shigeo Fuji, et al.
International Journal of Hematology|February 26, 2013
Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimensSatoshi Yamasaki, Akiko Miyagi-Maeshima, Yasuo Kakugawa, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|March 23, 2026
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantationShigeo Fuji, Akihiro Ohmoto, Yuho Najima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2017
Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell TransplantationIchiro Kawashima, Yoshihiro Inamoto, Akiko Miyagi Maeshima, et al.
British Journal of Haematology|December 1, 2023
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantationShigeo Fuji, Junichi Sugita, Yuho Najima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2019
Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working GroupAkihito Shinohara, Kumi Oshima, Shigeo Fuji, et al.
Annals of Hematology|January 15, 2022
Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphomaAkio Onishi, Shigeo Fuji, Shigehisa Kitano, et al.
Bone Marrow Transplantation|May 8, 2021
Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donorsSouichi Shiratori, Junichi Sugita, Shigeo Fuji, et al.
Bone Marrow Transplantation|August 7, 2023
Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular TherapyShigeo Fuji, Akitoshi Hakoda, Junya Kanda, et al.
Annals of Hematology|November 10, 2023
Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infectionKatsuto Takenaka, Shigeo Fuji, Toshihiro Matsukawa, et al.
Bone Marrow Transplantation|April 30, 2021
Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantationKaito Harada, Shun-Ichi Kimura, Shigeo Fuji, et al.
International Journal of Hematology|February 26, 2013
Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimensSatoshi Yamasaki, Akiko Miyagi-Maeshima, Yasuo Kakugawa, et al.
Pageof 20